Skip to main content
Erschienen in: Virchows Archiv 5/2023

23.09.2023 | BRIEF REPORT

Frequent nuclear β-catenin expression in pulmonary enteric-type adenocarcinoma according to the current World Health Organization criteria

verfasst von: Satsuki Kishikawa, Takuo Hayashi, Kazuya Takamochi, Ayako Ura, Noriko Sasahara, Tsuyoshi Saito, Kenji Suzuki, Takashi Yao, on behalf of the Tokyo Metropolitan Innovative oncology research Group (TMIG)

Erschienen in: Virchows Archiv | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Based on the current World Health Organization classification criteria, five of 3895 consecutive cases of surgically resected primary lung carcinomas (0.13%) categorized as enteric-type were analyzed. Three cases completely comprised tumor cells that resemble colorectal adenocarcinoma, while the other two cases exhibited features of conventional adenocarcinomas admixed with enteric components. Immunohistochemically, all patients expressed at least three of the five intestinal markers: CDX2, CK20, HNF4α, MUC2, and SATB2. None of the patients expressed TTF-1 and NKX3.1. Three cases showed nuclear accumulation of β-catenin, indicating activation of the Wnt/β-catenin signaling pathway; APC mutations were detected in one of these cases. TP53 mutations were detected in three cases. Mutated EGFR or ALK fusions were not detected. Our study demonstrates that pulmonary enteric-type adenocarcinomas share immunohistochemical features and genetic alterations with colorectal adenocarcinomas, which are characterized by frequent activation of the Wnt/β-catenin signaling pathway and a lack of actionable mutations.
Literatur
1.
Zurück zum Zitat Tsao MS, Fraser RS (1991) Primary pulmonary adenocarcinoma with enteric differentiation. Cancer 68:1754–1757 CrossRefPubMed Tsao MS, Fraser RS (1991) Primary pulmonary adenocarcinoma with enteric differentiation. Cancer 68:1754–1757 CrossRefPubMed
2.
Zurück zum Zitat Join D, MacMahon H, Nakatani Y et al (2021) Enteric-type adenocarcinoma. WHO classification of tumors series, thoracic tumors. Lyon, France, International Agency for Research on Cancer, pp 83–84 Join D, MacMahon H, Nakatani Y et al (2021) Enteric-type adenocarcinoma. WHO classification of tumors series, thoracic tumors. Lyon, France, International Agency for Research on Cancer, pp 83–84
4.
Zurück zum Zitat Zhao L, Huang S, Liu J et al (2017) Clinicopathological, radiographic, and oncogenic features of primary pulmonary enteric adenocarcinoma in comparison with invasive adenocarcinoma in resection specimens. Medicine (Baltimore) (2017) 96:e8153 CrossRefPubMed Zhao L, Huang S, Liu J et al (2017) Clinicopathological, radiographic, and oncogenic features of primary pulmonary enteric adenocarcinoma in comparison with invasive adenocarcinoma in resection specimens. Medicine (Baltimore) (2017) 96:e8153 CrossRefPubMed
5.
Zurück zum Zitat Zhang J, Xiang C, Han Y et al (2019) Differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal carcinoma with the assistance of next-generation sequencing and immunohistochemistry. J Cancer Res Clin Oncol 145:269–279 CrossRefPubMed Zhang J, Xiang C, Han Y et al (2019) Differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal carcinoma with the assistance of next-generation sequencing and immunohistochemistry. J Cancer Res Clin Oncol 145:269–279 CrossRefPubMed
6.
Zurück zum Zitat Liu Y, Lu T, Yuan M et al (2023) Genomic and transcriptomic insights into the precision treatment of pulmonary enteric adenocarcinoma. Lung Cancer 179:107169 CrossRefPubMed Liu Y, Lu T, Yuan M et al (2023) Genomic and transcriptomic insights into the precision treatment of pulmonary enteric adenocarcinoma. Lung Cancer 179:107169 CrossRefPubMed
7.
Zurück zum Zitat Kishikawa S, Hayashi T, Saito T et al (2022) Distinct properties of pure- and mixed-type high-grade fetal lung adenocarcinomas by genetic profiling and transcription factor expression. Virchows Arch 480:609–619 CrossRefPubMed Kishikawa S, Hayashi T, Saito T et al (2022) Distinct properties of pure- and mixed-type high-grade fetal lung adenocarcinomas by genetic profiling and transcription factor expression. Virchows Arch 480:609–619 CrossRefPubMed
8.
Zurück zum Zitat Boland CR, Thibodeau SN, Hamilton SR et al (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248–5257 PubMed Boland CR, Thibodeau SN, Hamilton SR et al (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248–5257 PubMed
9.
Zurück zum Zitat Matsushima J, Yazawa T, Suzuki M et al (2017) Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma. Hum Pathol 64:179–185 CrossRefPubMed Matsushima J, Yazawa T, Suzuki M et al (2017) Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma. Hum Pathol 64:179–185 CrossRefPubMed
10.
Zurück zum Zitat Bian T, Zhao J, Feng J et al (2017) Combination of cadherin-17 and SATB homeobox 2 serves as potential optimal makers for the differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal adenocarcinoma. Oncotarget 8:63442–63452 CrossRefPubMedPubMedCentral Bian T, Zhao J, Feng J et al (2017) Combination of cadherin-17 and SATB homeobox 2 serves as potential optimal makers for the differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal adenocarcinoma. Oncotarget 8:63442–63452 CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Jurmeister P, Schöler A, Arnold A et al (2019) DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer. Mod Pathol 2019:32:855–865 CrossRefPubMed Jurmeister P, Schöler A, Arnold A et al (2019) DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer. Mod Pathol 2019:32:855–865 CrossRefPubMed
12.
Zurück zum Zitat Jurmeister P, Vollbrecht C, Behnke A et al (2019) Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options. Lung Cancer 138:43–51 CrossRefPubMed Jurmeister P, Vollbrecht C, Behnke A et al (2019) Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options. Lung Cancer 138:43–51 CrossRefPubMed
13.
Zurück zum Zitat Xie M, Chen D, Li Y et al (2022) Genetic mutation profiles and immune microenvironment analysis of pulmonary enteric adenocarcinoma. Diagn Pathol 17:30 CrossRefPubMedPubMedCentral Xie M, Chen D, Li Y et al (2022) Genetic mutation profiles and immune microenvironment analysis of pulmonary enteric adenocarcinoma. Diagn Pathol 17:30 CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Chen M, Liu P, Yan F et al (2018) Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy. J Transl Med 16:81 CrossRefPubMedPubMedCentral Chen M, Liu P, Yan F et al (2018) Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy. J Transl Med 16:81 CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Skalova A, Sar A, Laco J et al (2018) The role of SATB2 as a diagnostic marker of sinonasal intestinal-type adenocarcinoma. Appl Immunohistochem Mol Morphol 26:140–146 CrossRefPubMed Skalova A, Sar A, Laco J et al (2018) The role of SATB2 as a diagnostic marker of sinonasal intestinal-type adenocarcinoma. Appl Immunohistochem Mol Morphol 26:140–146 CrossRefPubMed
17.
Zurück zum Zitat Sjöstedt S, Schmidt AY, Vieira FG et al (2021) Major driver mutations are shared between sinonasal intestinal-type adenocarcinoma and the morphologically identical colorectal adenocarcinoma. J Cancer Res Clin Oncol 147:1019–1027 CrossRefPubMed Sjöstedt S, Schmidt AY, Vieira FG et al (2021) Major driver mutations are shared between sinonasal intestinal-type adenocarcinoma and the morphologically identical colorectal adenocarcinoma. J Cancer Res Clin Oncol 147:1019–1027 CrossRefPubMed
Metadaten
Titel
Frequent nuclear β-catenin expression in pulmonary enteric-type adenocarcinoma according to the current World Health Organization criteria
verfasst von
Satsuki Kishikawa
Takuo Hayashi
Kazuya Takamochi
Ayako Ura
Noriko Sasahara
Tsuyoshi Saito
Kenji Suzuki
Takashi Yao
on behalf of the Tokyo Metropolitan Innovative oncology research Group (TMIG)
Publikationsdatum
23.09.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 5/2023
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-023-03657-9

Weitere Artikel der Ausgabe 5/2023

Virchows Archiv 5/2023 Zur Ausgabe

Neu im Fachgebiet Pathologie

30.10.2023 | Morphin | CME

Nachweis eines Heroinkonsums

Tücken und Tricks

12.10.2023 | Osteosarkom | Schwerpunkt: Kindliche Tumoren

Knochentumoren des Kindes- und Jugendalters

11.10.2023 | Neuroblastom | Schwerpunkt: Kindliche Tumoren

Periphere neuroblastische Tumoren im Kindesalter